Publication | Open Access

Activation of CD1d-restricted natural killer T cells can inhibit cancer cell proliferation during chemotherapy by promoting the immune responses in murine mesothelioma

Murine MesotheliomaCancer Cell ProliferationCancer ImmunosurveillanceT-regulatory CellImmunologyImmunoeditingImmune Checkpoint InhibitorAutoimmunityImmune ResponsesCellular Immune ResponseImmunotherapyMedicineCell BiologyTumor Microenvironment